QQQ
+ 0.00
387.12
+ 0%
BTC/USD
-948.94
56235.13
-1.66%
DIA
+ 0.00
340.46
+ 0%
SPY
+ 0.04
450.46
+ 0.01%
TLT
+ 0.00
152.34
+ 0%
GLD
+ 0.05
166.11
+ 0.03%

Expert Ratings For Vertex Pharmaceuticals

September 9, 2021 1:19 pm
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More
Expert Ratings For Vertex Pharmaceuticals

Vertex Pharmaceuticals (NASDAQ:VRTX) has observed the following analyst ratings within the last quarter:

Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish
Total Ratings 1 3 3 3 0
Last 30 Days 0 0 1 0 0
1 Month Ago 0 0 0 1 0
2 Months Ago 0 2 1 2 0
3 Months Ago 1 1 1 0 0

In the last 3 months, 10 analysts have offered 12-month price targets for Vertex Pharmaceuticals. The company has an average price target of $232.5 with a high of $331.00 and a low of $170.00.

Below is a summary of how these 10 analysts rated Vertex Pharmaceuticals over the past 3 months. The greater the number of bullish ratings, the more positive analysts are on the stock and the greater the number of bearish ratings, the move negative analysts are on the stock

price target chart

This current average has decreased by 6.08% from the previous average price target of $247.56.

What Are Analyst Ratings?

Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter.

Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.

For the latest in financial news, exclusive stories, memes follow Benzinga on Twitter, Facebook & Instagram. For the best interviews, stock market talk & videos, subscribe to Benzinga Podcasts and our YouTube channel.

Posted-In:

Analyst Ratings

Related Articles

Expert Ratings For Vertex Pharmaceuticals

Expert Ratings For Vertex Pharmaceuticals

Over the past 3 months, 5 analysts have published their opinion on Vertex Pharmaceuticals (NASDAQ:VRTX) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year. read more
Where Vertex Pharmaceuticals Stands With Analysts

Where Vertex Pharmaceuticals Stands With Analysts

Vertex Pharmaceuticals (NASDAQ:VRTX) has observed the following analyst ratings within the last quarter: read more
Where Vertex Pharmaceuticals Stands With Analysts

Where Vertex Pharmaceuticals Stands With Analysts

Over the past 3 months, 16 analysts have published their opinion on Vertex Pharmaceuticals (NASDAQ:VRTX) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year. read more

Expert Ratings for Vertex Pharmaceuticals

Analysts have provided the following ratings for Vertex Pharmaceuticals (NASDAQ:VRTX) within the last quarter: Last 30 Days 1 Month Ago 2 Months Ago read more